Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
Cariou B, Hadjadj S, Wargny M, et al.
Diabetologia. Pub online 29 May 2020
Leggi
Oral antidiabetes agents for the management of inpatient hyperglycaemia: so far, yet so close
Koufakis T, Mustafa OG, Zebekakis P, Kotsa K
Diabet Med. Pub. online 23 May 2020
Leggi
Out-of-pocket spending for insulin, diabetes-related supplies, and other health care services among privately insured us patients with type 1 diabetes
Chua KP, Lee JM, Conti RM
JAMA Intern Med. Pub. online 1 June 2020
Leggi
Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial
Aronson R, Li A, Brown RE
Lancet Diabetes Endocrinol. 2020;8(6):511-23
Leggi
Managing diabetes in pregnancy before, during, and after COVID-19
Murphy HR
Diabetes Technol Ther. Pub. online 18 May 2020
Leggi
Risk of severe maternal morbidity or death in relation to elevated hemoglobin A1c preconception, and in early pregnancy: A population-based cohort study
Davidson AJF, Park AL, Berger H, et al.
Plos Medicine. Pub. online 19 May 2020
Leggi
Using insulin to treat poorly controlled type 2 diabetes in 2020
Hirsch IB, Gaudiani LM
JAMA. Pub. online 22 May 2020
Leggi
Glycemic control in type 1 diabetes mellitus during COVID-19 quarantine and the role of in-home physical activity
Tornese G, Ceconi V, Monasta L, et al.
Diabetes Technol Ther. Pub. online 21 May 2020
Leggi